BUSABrandes U.S. Value ETF
Seeks long term capital appreciation.
By Brandes · Launched 2023
Annual Cost
0.60%
#3,235 of 5,861 · average
Fund Size
$298M
#1,997 of 5,861 · mid-size
Return (1Y)Goal
+23.6%
Track Record
2 years
#3,143 of 5,861 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,570+25.7%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 24.4% of fund✓ well diversified
Merck & Co., Inc
2.9%
Citigroup Inc.
2.8%
Textron Inc.
2.5%
Pfizer Inc.
2.4%
FedEx Corporation
2.4%
Bank of America Corp.
2.4%
Halliburton Company
2.4%
CHEVRON CORP
2.3%
The Cigna Group
2.2%
Becton, Dickinson and Company
2.2%
Asset allocation
Stocks
98.2%
Cash
1.9%
By sector
Healthcare
26.1%
Financial Services
21.4%
Industrials
12.6%
Technology
9.7%
Energy
6.5%
Consumer Cyclical
5.6%
Communication
5.5%
Consumer Defensive
5.3%
Other
7.4%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
12.1%Moderate
Year-on-year price swings
Max drawdown
-14.2%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks long term capital appreciation.
- Strategy
- Actively manages a portfolio primarily invested in equity securities of U.S. companies, focusing on undervalued stocks based on intrinsic value analysis. Typically targets companies with market capitalizations greater than $5 billion.
- Inception date
- October 3, 2023
- Fund family
- Brandes
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at BUSA. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04